CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
Go back to CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign| (AMEX: CSLLY) | Delayed: 32.41 +0.20 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.21 | 52 Week High | $45.60 | |||
| Open | $32.07 | 52 Week Low | $33.39 | |||
| Day High | $32.41 | P/E | N/A | |||
| Day Low | $32.07 | EPS | $0.00 | |||
| Volume | 1,812 | |||||



